Literature DB >> 10929670

Lipid transporters: membrane transport systems for cholesterol and fatty acids.

N A Abumrad1, Z Sfeir, M A Connelly, C Coburn.   

Abstract

Lipophilic molecules can passively diffuse across cell membranes, a process that is driven by the concentration gradient, by availability of acceptors to facilitate desorption from the bilayer, and by cellular metabolism. However, evidence has accumulated that supports the existence of specialized, protein-facilitated membrane transport systems for many lipophilic molecules. This has generated considerable debate regarding why such systems need to exist. The present review summarizes recent developments related to the membrane transport systems for cholesterol and fatty acids, which have been shown to involve structurally related proteins. General similarities of the cholesterol and fatty acid systems to other lipid transport systems (briefly discussed in the Introduction section) are highlighted in the Conclusion section. The overall aim of the present review is to illustrate why lipid transporters are needed in vivo, and how they accomplish specific functions that can not be met by lipid diffusion alone.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10929670     DOI: 10.1097/00075197-200007000-00003

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  11 in total

1.  Albumin and mammalian cell culture: implications for biotechnology applications.

Authors:  Geoffrey L Francis
Journal:  Cytotechnology       Date:  2010-04-06       Impact factor: 2.058

2.  The fatty acid transport protein (FATP) family: very long chain acyl-CoA synthetases or solute carriers?

Authors:  Zhenzhen Jia; Zhengtong Pei; Dony Maiguel; Cicely J Toomer; Paul A Watkins
Journal:  J Mol Neurosci       Date:  2007-09       Impact factor: 3.444

Review 3.  Translocation of long chain fatty acids across the plasma membrane--lipid rafts and fatty acid transport proteins.

Authors:  Robert Ehehalt; Joachim Füllekrug; Jürgen Pohl; Axel Ring; Thomas Herrmann; Wolfgang Stremmel
Journal:  Mol Cell Biochem       Date:  2006-02-14       Impact factor: 3.396

4.  Ceramide as a mediator of non-alcoholic Fatty liver disease and associated atherosclerosis.

Authors:  Takhar Kasumov; Ling Li; Min Li; Kailash Gulshan; John P Kirwan; Xiuli Liu; Stephen Previs; Belinda Willard; Jonathan D Smith; Arthur McCullough
Journal:  PLoS One       Date:  2015-05-20       Impact factor: 3.240

5.  Transcriptomic difference in bovine blastocysts following vitrification and slow freezing at morula stage.

Authors:  Alisha Gupta; Jaswant Singh; Isabelle Dufort; Claude Robert; Fernanda Caminha Faustino Dias; Muhammad Anzar
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

Review 6.  Insulin signaling in health and disease.

Authors:  Alan R Saltiel
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

7.  Regulation of FAT/CD36 mRNA gene expression by long chain fatty acids in the differentiated 3T3-L1 cells.

Authors:  Yingkui Yang; Min Chen; Tara J Loux; Carroll M Harmon
Journal:  Pediatr Surg Int       Date:  2007-05-22       Impact factor: 2.003

8.  Lipoprotein binding preference of CD36 is altered by filipin treatment.

Authors:  Jianshe Zhang; Wuying Chu; Ian Crandall
Journal:  Lipids Health Dis       Date:  2008-06-26       Impact factor: 3.876

9.  Uptake of long chain fatty acids is regulated by dynamic interaction of FAT/CD36 with cholesterol/sphingolipid enriched microdomains (lipid rafts).

Authors:  Robert Ehehalt; Richard Sparla; Hasan Kulaksiz; Thomas Herrmann; Joachim Füllekrug; Wolfgang Stremmel
Journal:  BMC Cell Biol       Date:  2008-08-13       Impact factor: 4.241

10.  Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis.

Authors:  Andras Ladanyi; Abir Mukherjee; Hilary A Kenny; Alyssa Johnson; Anirban K Mitra; Sinju Sundaresan; Kristin M Nieman; Gloria Pascual; Salvador Aznar Benitah; Anthony Montag; S Diane Yamada; Nada A Abumrad; Ernst Lengyel
Journal:  Oncogene       Date:  2018-02-05       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.